Date: 2014-09-11
Type of information: Services contract
Compound: Data Driven Medicine platform
Company: Sophia Genetics (Switzerland) undisclosed leading Turkish laboratory (Turkey)
Therapeutic area: Technology - Services
Type agreement: services
Action mechanism: Sophia Genetics\' Data Driven Medicine Platform (DDM) is a software-as-a-service platform designed to perform routine diagnostic testing. It integrates modules enabling analysis and protection of clinical next generation sequencing (NGS) data. The core module processes and analyzes data from multiple panels of selected genes, exomes or genomes from raw patient DNA sequence data generated by an NGS platform. DNA sequence files are automatically uploaded and immediately processed using advanced algorithms and machine learning assuring highest accuracy. The platform integrates modules for clinical bioinformatics and clinical reports while respecting patient data privacy through advanced encryption techniques, secured data storage to analyzeg and interprete genetic information.
Disease:
Details: * On September 11, 2014, Sophia Genetics has expanded its European customer base through an agreement with a leading Turkish laboratory. This follows a surge in demand for the company’s Clinical Genomics offerings among laboratories and hospitals in Germany, France and Italy, with additional customer relationships in these countries established in August.
This customer now gains access to Sophia Genetics’ innovative Data Driven Medicine platform, which offers securely-hosted Software as a Service module covering the bioinformatics analysis protocol, the validation and quality control process, the presentation of results of genetic tests to clinicians and the protection of patient DNA sequence data through safe storage and sharing.
Financial terms:
Latest news:
